Global biosecurity in a complex, dynamic world

Complexity

Volumn 14, Issue 1, 2008, Pages 71-88

  Wilson, Brenda A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Biosecurity; Disease transmission; Emerging infectious diseases; Global health; Pathogen evolution

Indexed keywords

EID: 53649096375     PISSN: 10762787     EISSN: 10990526     Source Type: Journal    
DOI: 10.1002/cplx.20246     Document Type: Note

References (109)

1. The Institute for Medicine of the National Academies, Report of the Committee on Emerging Microbial Threats to Health in the 21st Century on "Microbial threats to health: emergence, detection, and response", http://books.nap.edu/openbook.php?isbn=030908864X. Accessed on 07/05/08.
2. Lopez, A.D.; Mathers, C.D.; Ezzati, M.; Jamison, D.T.; Murray, C.J. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006, 367, 1747-1757.
3. Lopez, A.D.; Mathers, C.D. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol 2006, 100, 481-499.
4. Minino, A.M.; Heron, M.P.; Smith, B.L. Deaths: Preliminary data for 2004. Natl Vital Stat Rep 2006, 54, 1-49.
5. Ferez, D.R.; Sorrell, E.M.; Donis, R.O. Avian influenza: An omnipresent pandemic threat. Pediatr Infect Dis J 2005, 24, S208-S216; discussion S215.
6. Altman, S.; Bassler, B.L.; Beckwith, J.; Belfort, M.; Berg, H.C.; Bloom, B.; Brenchley, J.E.; Campbell, A.; Collier, R.J.; Connell, N. An open letter to Ellas Zerhouni. Science 2005, 307, 1409-1410.
7. Global Security Newswire, "Bioterror Threat Exaggerated, Scientist Says" Global Security Newswire, http://www.nti.org/d_newswire/issues/ W_2008_5_23.htrnl#8AE9E247. Accessed on 07/05/08.
8. Nuclear Threat Initiative, World Wide Web URL: http://vww.nti.org. Accessed on 07/05/08.
9. Food and Drug Administration, http://www.cfsan.fda.gov/∼dms/spinacqa. html. Accessed on 10/20/06.
10. Robert E. Brackett. FDA's role in tracking and resolving the recent E. coli spinach outbreak. In: U.S. Senate Committee on Health, Education, Labor and Pensions; U.S. Senate, 2006. http://www.fda.gov/ola/2006/ foodsafety1115.html. Accessed on 07/05/08.
11. Hileman, B. Food safety system: Contaminated spinach prompts calls for major overhaul. C & EN News 2006, 84, 28-30.
12. Balter, M. Emerging diseases. On the trail of Ebola and Marburg viruses. Science 2000, 290, 923-925.
13. Westover, K.M.; Hughes A.L. Molecular evolution of viral fusion and matrix protein genes and phylogenetic relationships among the Paramyxoviridae. Mol Phylogenet Evol 2001, 21, 128-134.
14. Barrett, T. Morbillivirus infections, with special emphasis on morbilliviruses of carnivores. Vet Microbiol 1999, 69, 3-13.
15. Manson, J.C.; Cancellotti, E.; Hart, P.; Bishop, M.T.; Barron, R.M. The transmissible spongiform encephalopathies: Emerging and declining epidemics. Biochem Soc Trans 2006, 34, 1155-1158.
16. Centers for Disease Control and Prevention, http://www.cdc.gov/ncidod/ dvrd/bee. Accessed on 07/05/08.
17. Bradley, R.; Collee, J.G.; Liberski, P.P. Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: Part 1. Folia Neuropathol 2006, 44, 93-101.
18. Collee, J.G.; Bradley, R.; Libersti, P.E Variant CJD (vCJD) and bovine spongiform encephalopathy (BSE): 10 and 20 years on: Part 2. Folia Neuropathol 2006, 44, 102-110.
19. Ricketts, M.N. Public health and the BSE epidemic. Curr Top Microbiol Immunol 2004, 284, 99-119.
20. Prempeh, H.; Smith, R.; Muller, B. Foot and mouth disease: The human consequences. The health consequences are slight, the economic ones huge. BMJ 2001, 322, 565-566.
21. Campbell, D.; Lee R. Carnage by Computer The blackboard economics of the 2001 foot and mouth epidemic. Soc Leg Stud 2003, 12, 425-459.
22. Foot-and-Mouth Disease, http://www.foot-and-moutb-disease.com. Accessed on 07/05/08.
23. World Health Organization, http://www.oie.int/eng/maladies/fiches/a_A010. htm. Accessed on 07/05/08.
24. Blaustein, R.J. Kudzu's invasion into Southern United States life and culture. In: The Great Reshuffling: Human Dimensions of Invasive Species, McNeeley, J.A., Ed.; International Union for Conservation of Nature and Natural Resources; 2001. The World Conservation Union: 55-62.
25. Hoots, D.; Baldwin, J. Kudzu: The Vine to Love or Hate. Kodak, TN: Suntop Press, 1996.
26. Miller, J.H. Controlling exotic plants in your forest Forest Landowner 1999, 58, 60-64.
27. Fernner, F.; Fantini, B. Biological Control of Vertebrate Pests: The History of Myxomatosis, an Experiment in Evolution. Cambridge, U.K.: Oxford University Press; 1999.
28. Hahn, B.H.; Shaw, G.M.; De Cock, K.M.; Sharp, P.M. AIDS as a zoonosis: Scientific and public health implications. Science 2000, 287, 607-614.
29. Rambaut, A.; Posada, D.; Crandall, K.A.; Holmes, E.C. The causes and consequences of HIV evolution. Nat Rev Genet 2004, 5, 52-61.
30. Hutchinson, J.F. The biology and evolution of HIV. Annu Rev Anthropol 2001, 30, 85-108.
31. Gottlieb, S. AIDS deaths fall by nearly one half. BMJ 1998, 317, 1032.
32. Anderson, R.N.; Smith, B.L. Deaths: Leading causes for 2001. Natl Vital Stat Rep 2003, 52, 1-85.
33. O'Brien, T.R.; Padian, N.S.; Hodge, T.; Goedert, J.J.; O'Brien, S.J.; Camngton, M. CCR-5 genotype and sexual transmission of HIV-I. AIDS 1998, 12, 444-445.
34. Samson, M.; libert, F.; Doranz, B.J.; Rucker, J.; Liesnard, C.; Farber, C.M.; Saragosti, S.; Lapoumeroulie, C.; Cognaux, J.; Forceille, C. Resistance to HIV-I infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemoldne receptor gene. Nature 1996, 382, 722-725.
35. Stebbing, J.; Hatzimichael, E.; Bower, M.; Winston, A The rationale and development of new drugs to treat HIV infection. Med Chem 2005, 1, 635-642.
36. Grundmann, H.; Aires-de-Sousa, M.; Boyce, J.; Tiemersma, E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006, 368, 874-885.
37. Wilson, B.A. Changing paradigms in combating antibiotic-resistant bacteria. BIOforum Int 2002, 6, 312-314.
38. Wilson, B.A.; Salyers, A.A. Ecology and physiology of infectious bacteria-Implications for biotechnology. Curr Opin Biotechnol 2002, 13, 267-274.
39. Teuber, M. Veterinary use and antibiotic resistance Curr Opin Microbiol 2001, 4, 493-499.
40. Shoemaker, N.B.; Vlamakis, H.; Hayes, K.; Salyers, A.A. Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl Environ Microbiol 2001, 67, 561-568.
41. Tomioka, H. Current status of some antituberculosis drugs and the development of new anutuberculous agents with special reference to their in vitro and in vivo antimicrobial activities. Curr Pharm Des 2006, 12, 4047-4070.
42. Toungoussova, O.S.; Bjune, G.; Caugant, D.A. Epidemic of tuberculosis in the former Soviet Union: Social and biological reasons. Tuberculosis (Edinb) 2006, 86, 1-10.
43. Laughon, B.E New tuberculosis drugs in development Curr Top Med; Chem 2007, 7, 463-473.
44. Swanson, M.S.; Hammer, B.K. Legionella pneumophila pathogesesis: A fateful journey from amoebae to macrophages. Annu Rev Microbiol 2000, 54, 567-613.
45. Seenivasan, M.H.; Yu, V.L.; Muder, R.R. Legionnaires' disease in long-term care facilities: Overview and proposed solutions. J Am Geriatr Soc 2005, 53, 875-880.
46. CDC. Outbreaks of gastroenteritis associated with noroviruses on cruise ships - United States, 2002. Morbidity and Mortality Weekly Report 2002, 51, 1112-1115.
47. CDC. Norwalk-like virus: Public health consequences and outbreak management Morbidity and Mortality Weekly Report 2001, 50, RR-9.
48. CDC. Norovirus outbreak among evacuees from hurricane Katrina - Houston, Texas, September 2005. Morbidity and Mortality Weekly Report 2005, 54, 1016-1018.
49. Staples, J.E.; Kubota, K.A.; Chalcraft, L.G.; Mead, P.S.; Petersen, J.M. Epidemiologic and molecular analysis of human tularemia, United States, 1964-2004. Emerg Infect Dis 2006, 12, 1113-1118.
50. Feldman, K.A.; Enscore, R.E.; Lathrop, S.L.; Matyas, B.T.; McGuill, M.; Schriefer, M.E.; Stiles-Enos, D.; Dennis, D.T.; Petersen, L.R.; Hayes, E.B. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med 2001, 345, 1601-1606.
51. Frias-Lopez, J.; Bonheyo, G.T.; Jin, Q.; Fouke, B.W. Cyanobacteria associated with coral black band disease in Caribbean and Indo-Pacific Reefs. Appl Environ Microbiol 2003, 69, 2409-2413.
52. Frias-Lopez, J.; Zerkle, A.L.; Bonheyo, G.T.; Fouke, B.W. Partitioning of bacterial communities between seawater and healthy, black band diseased, and dead coral surfaces. Appl Environ Microbiol 2002, 68, 2214-2228.
53. CDC: Multistate outbreak of monkeypox - Illinois, Indiana, and Wisconsin, 2003. Morbidity and Mortality Weekly Report 2003, 52, 537-540.
54. CDC. Update: Multistate outbreak of monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. Morbidity and Mortality Weekly Report 2003, 52, 561-564, 642-646.
55. Reed, K.D.; Melski, J.W.; Graham, M.B.; Regnery, R.L; Sotir, M.J.; Wegner, U.V.; Kazmierczak, J.J.; Stratman, E.J.; Li, Y.; Fairley, J.A. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 2004, 350, 342-350.
56. Guarner, J.; Johnson, B.J.; Paddock, C.D.; Shieh, W.J.; Goldsmith, C.S.; Reynolds, M.G.; Damon, I.K.; Regnery, R.L.; Zaki S.R. Monkeypox transmission and pathogenesis in prairie dogs. Emerg Infect Dis 2004, 10, 426-431.
57. Heymann, D.L.; Szczeniowski, M.; Esteves, K. Re-emergence of monkeypox in Africa: A review of the past six years. Br Med Bull 1998, 54, 693-702.
58. Hutin, Y.J.; Williams, R.J.; Malfait, P.; Pebody, R.; Loparev, V.M.; Ropp, S.L; Rodriguez, M.; Knight, J.C.; Tshiofco, F.K.; Khan, A.S. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis 2001, 7, 434-438.
59. CDC. Monkeypox Factsheet - Embargoed African rodents and monkeypox virus available at http://www.cdc.gov/ncidod/monkeypox/. Accessed on 07/05/08.
60. Sack, D.A.; Sack, R.B.; Nair, G.S.; Siddique, A.K. Cholera Lancet 2004, 363, 223-233.
61. Tickner, J.; Gouveia-Vigeant, T. The 1991 cholera epidemic in Peru: Not a case of precaution gone awry. Risk Anal 2005, 25, 495-502.
62. Griffith, D.C.; Kelly-Hope, L.A.; Miller, MA Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg 2006, 75, 973-977.
63. Sack, D.A.; Sack, R.B.; Chaignat, C.L. Getting serious about cholera. N Engl J Med 2006, 355, 649-651,
64. Faruque, S.M.; Sack, D.A.; Sack, R.B.; Colwell, R.R.; Takeda, Y.; Nair G.B. Emergence and evolution of Vibrio cholerae O139. Proc. Natl Acad Sci USA 2003, 100, 1304-1309.
65. Faruque, S.M.; Naser, I.B.; Islam, M.J.; Faruque, A.S.; Ghosh, A.N.; Nair, G.B.; Sack, D.A; Mekalanos, J.J. Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc Natl Acad Sci USA 2005, 102, 1702-1707.
66. Huq, A; Sack, R.B.; Nizam, A.; Longini, I.M.; Nair, G.B.; Ali, A.; Morris, J.G., Jr.; Khan, M.N.; Siddique, A.K.; Yunus, M. Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh. Appl Environ Microbiol 2005, 71, 4645-4654.
67. Pascual, M.; Bouma, M.J.; Dobson, A.P. Cholera and climate: Revisiting the quantitative evidence. Microbes Infect 2002, 4, 237-245.
68. Faruque, S.M.; Islam, M.J.; Ahmad, Q.S.; Faruque, A.S.; Sack, D.A.; Nair, G.B.; Mekalanos, J.J. Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage. Proc Natl Acad Sci USA 2005, 102, 6119-6124.
69. Merrell, D.S.; Butler, S.M.; Qadri, F.; Dolganov, NA; Atom, A.; Cohen, M.B.; Calderwood, S.B.; Schoolnik, G.K.; Camilli, A. Host-induced epidemic spread of the cholera bacterium. Nature 2002, 417, 642-645.
70. Tsai, T.F.; Popovici, F.; Cernescu, C.; Campbell, G.L.; Nedelcu, N.I. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998, 352, 767-771.
71. U.S. Geological Survey, http://diseasemaps.usgs.gov/wnv_us_human.html. Accessed on 07/05/08.
72. Lanciotti, R.S.; Hoehrig, J.T.; Deubei, V.; Smith, J.; Parker, M.; Steele, K.; Crise, B.; Volpe, K.E.; Crabtree, M.B.; Scherret, J.H. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999, 286, 2333-2337.
73. CDC. Outbreak of acute illness - Southwestern United States, 1993. Morbidity and Mortality Weekly Report 1993, 42, 421-424.
74. CDC. Update: Hantavirus Disease - United States, 1993. Morbidity and Mortality Weekly Report 1993, 42, 612-614.
75. Chapman, L.E.; Khabbaz, H.F. Etiology and epidemiology of the four corners hantavirus outbreak. Infect Agents Dis 1994, 3, 234-244.
76. Bremner, J.A. Hantavirus infections and outbreaks in 1993. Commun Dis Rep CDR Rev 1994, 4, R5-R9.
77. Williams, E.S. Chronic wasting disease. Vet Pathol 2005, 42, 530-549.
78. Hamir, A.N.; Kunkle, R.A.; Cudip, R.C.; Miller, J.M.; O'Hourke, K.I.; Williams, E.S.; Miller, M.W; Stack, M.J.; Chaplin, M.J.; Rieht, J.A. Experimental transmission of chronic wasting disease agent from mule deer to cattle by the intracerebral route. J Vet Diagn Invest 2005, 17, 276-281.
79. Moore, R.A.; Vorberg, I.; Priola, SA Species barriers in prion diseases-brief review. Arch Virol Suppl 2005, 19, 187-202.
80. Belshe, R.B. The origins of pandemic influenza-lessons from the 1918 virus. N Engl J Med 2005, 353, 2209-2211.
81. Beigel, J.H.; Farrar, J.; Han, A.M.; Hayden, F.G.; Hyer, R.; de Jong, M.D.; Lochindarat, S.; Nguyen, T.K.; Nguyen, T.H.; Tran, T.H. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005, 353, 1374-1385.
82. Ungchusak, K.; Auewarakul, P.; Dowell, S.F.; Kitphati, R.; Auwanit, W.; Puthavathana, P.; Uiprasertkul, M.; Boonnak, K.; Pittayawonganon, C.; Cox, N.J. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005, 352, 333-340.
83. Brankston, G.; Gitterman, L.; Hirji, Z.; Lemieux, C.; Gardam, M. Transmission of influenza A in human beings. Lancet Infect Dis 2007, 7, 257-265.
84. Shoham, D. Review: Molecular evolution and the feasibility of an avian influenza virus becoming a pandemic strain - A conceptual shift. Virus Genes 2006, 33, 127-132.
85. Cinti, S. Pandemic influenza: are we ready? Disaster Manag Response 2005, 3, 61-67.
86. U.S. National Research Council and the Institute for Medicine of the National Academies, Report of the Committee on Advances in Technology and the Prevention of their Application to Next Generation Biowarfare Threats on "Globalization, Biosecurity, and the Future of the life Sciences", http://books.nap.edu/catalog.php?record_id=11567. Accessed on 07/05/2008.
87. U.S. Department of Health and Human Services, National Institutes of Health, http://www.nih.gov/news/fundingresearchareas.htm. 2007. Accessed on 07/05/08.
88. World Health Organization, Global Outbreak Alert and Response Network (GOARN), http://www.who.int/csr/sars/goarn/en/. Accessed on 07/05/08.
89. World Health Organization, Global Early Warning System for Major Animal Diseases, including Zoonosis (GLEWS), http://www.who.int/zoonoses/outbreaks/en/. Accessed on 07/05/08.
90. World Health Organization, International Health Regulations (2005), http://www.who.int/csr/ihr/en/. Accessed on 07/05/08.
91. Potter, A.A.; Klashinsky, S.; Li, Y.; Frey, E.; Townsend, H.; Rogan, D.; Erickson, G.; Hinktey, S.; Klopfenstein, T.; Moxley, R.A. Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine 2004, 22, 362-369.
92. Colwell, R.R.; Huq, A.; Islam, M.S.; Aziz, K.M.; Yunus, M.; Khan, N.A.; Mahmud, A.; Sack, R.B.; Nair, G.B.; Chakraborty, J. Reduction of cholera in Bangladeshi villages by simple filtration. Proc Natl Acad Sci USA 2003, 100, 1051-1055.
93. CDC. Evolution of HIV/AIDS prevention programs - United States, 1981-2006. Morbidity and Mortality Weekly Report 2006, 55, 597-603.
94. CDC. Trends in HIV/ AIDS diagnoses-33 states, 2001-2004. Morbidity and Mortality Weekly Report 2005, 54, 1149-1153.
95. CDC. Racial/ethnic disparities in diagnoses of HTV/AIDS-33 states, 2001-2004. Morbidity and Mortality Weekly Report 2006, 55, 121-125.
96. CDC. HIV prevalence, unrecognized infectin, and HIV testing among men who have sex with men - five US cities, June 2004-April 2005. Morbidity and Mortality Weekly Report 2005, 54, 597-601.
97. Bartlett, J.A.; Path, M.J.; Demasi, R.; Hermes, A.; Quinn, I.; Mondou, E.; Rousseau F. An updated systematic overview of triple combination therapy in antiretrovkal-naive HIV-infected adults. AIDS 2006, 20, 2051-2064.
98. Ducati, R.G.; Ruffino-Netto, A.; Basso, LA; Santos, D.S. The resumption of consumption - A review on tuberculosis. Mem Inst Oswaldo Cruz 2006, 101, 697-714.
99. Volmink, J; Gamer, P. Interventions for promoting adherence to tuberculosis management. Cochrane Database Syst Rev 2000, CD000010.
100. German, C. Staving healthy. Playing chicken with our antibiotics. Overtreatment is creating dangerously resistent germs. Time 2002, 159, 98-101.
101. Enserink, M. Bioterrorism. Researchers question obsession with Cipro. Science 2001, 294, 759-761.
102. CDC. FoodNet, Foodborne Diseases Active Surveillance Network, http://www.cdc.gov/foodnet/. Accessed on 07/05/08.
103. Korczynski, M.S. The integration of process analytical technologies, concurrent validation, and parametric release programs in aseptic processing: Parenteral Drug Association. PDA J Pharm Sci Technol 2004, 58, 181-191.
104. Kvenberg, I.E.; Schwalm, D.J. Use of microbial data for hazard analysis and critical control point verification-Food and Drug Administration perspective. J Food Prot 2000, 63, 810-814.
105. Food Emergency Response Network - FERN Cooperative Agreement, http://www.fsis.usda.gov/About_FSIS/Cooperative_Agreements_FERN_2005/index.asp. Accessed on 07/05/08.
106. U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition, CARVER + Shock Software Tool for Food Defense and Terrorism, http://www.fda.gov/consumer/updates/carvershock061107.html. Accessed on 07/05/2008.
107. Osterholm, M.T.; Norgan, A.P. The role of irradiation in food safety. N Engl J Med 2004, 350, 1898-1901.
108. Thayer, D.W. Irradiation of food-helping to ensure food safety. N Engl J Med 2004, 350, 1811-1812.
109. Farnes, R.B.; Lichtenstein, A.H. Food irradiation: A safe and useful technology. Nutr Clin Care 2004, 7, 149-155.